Acute diagnostic biomarkers for spinal cord injury: Review of the literature and preliminary research report

World Neurosurgery

Volumn 83, Issue 5, 2015, Pages 867-878

  Yokobori, Shoji ^a,d   Zhang, Zhiqun ^b   Moghieb, Ahmed ^b   Mondello, Stefania ^c   Gajavelli, Shyam ^a   Dietrich, W Dalton ^a   Bramlett, Helen ^a   Hayes, Ronald L ^c   Wang, Michael ^a   Wang, Kevin K W ^b   Bullock, M Ross ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c BANYAN BIOMARKERS INC   (United States)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Biomarker; Pathophysiology; Spinal cord injury; Treatment

Indexed keywords

ALPHA2 SPECTRIN; BIOCHEMICAL MARKER; CLEAVED TAU PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B; SPECTRIN; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; NERVE PROTEIN;

DIAGNOSTIC VALUE; HUMAN; INJURY SEVERITY; NEUROFILAMENT; NONHUMAN; PATIENT MONITORING; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; REVIEW; SPINAL CORD INJURY; SYSTEMATIC REVIEW; ACUTE DISEASE; PROGNOSIS; SPINAL CORD INJURIES; TREATMENT OUTCOME;

ACUTE DISEASE; BIOLOGICAL MARKERS; HUMANS; NERVE TISSUE PROTEINS; PROGNOSIS; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 84929306247     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2013.03.012     Document Type: Review

References (121)

1. A. Ackery, C. Tator, and A. Krassioukov A global perspective on spinal cord injury epidemiology J Neurotrauma 21 2004 1355 1370
2. G. Agrawal, C. Kerr, N.V. Thakor, and A.H. All Characterization of graded multicenter animal spinal cord injury study contusion spinal cord injury using somatosensory-evoked potentials Spine (Phila Pa 1976) 35 2010 1122 1127
3. J.I. Akhtar, R.M. Spear, M.O. Senac, B.M. Peterson, and S.M. Diaz Detection of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain Pediatr Crit Care Med 4 2003 322 326
4. K.J. Anderson, S.W. Scheff, K.M. Miller, K.N. Roberts, L.K. Gilmer, C. Yang, and G. Shaw The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury J Neurotrauma 25 2008 1079 1085
5. S. Bandyopadhyay, H. Hennes, M.H. Gorelick, R.G. Wells, and C.M. Walsh-Kelly Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury Acad Emerg Med 12 2005 732 738
6. G. Baydas, V.S. Nedzvetskii, M. Tuzcu, A. Yasar, and S.V. Kirichenko Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E Eur J Pharmacol 462 2003 67 71
7. R.P. Berger, P.D. Adelson, M.C. Pierce, T. Dulani, L.D. Cassidy, and P.M. Kochanek Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children J Neurosurg 103 2005 61 68
8. R.P. Berger, S.R. Beers, R. Richichi, D. Wiesman, and P.D. Adelson Serum biomarker concentrations and outcome after pediatric traumatic brain injury J Neurotrauma 24 2007 1793 1801
9. R.P. Berger, T. Dulani, P.D. Adelson, J.M. Leventhal, R. Richichi, and P.M. Kochanek Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool Pediatrics 117 2006 325 332
10. R.P. Berger, M.C. Pierce, S.R. Wisniewski, P.D. Adelson, R.S. Clark, R.A. Ruppel, and P.M. Kochanek Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children Pediatrics 109 2002 E31
11. H. Brisby, K. Olmarker, L. Rosengren, C.G. Cederlund, and B. Rydevik Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica Spine (Phila Pa 1976) 24 1999 742 746
12. G.M. Brophy, J.A. Pineda, L. Papa, S.B. Lewis, A.B. Valadka, H.J. Hannay, S.C. Heaton, J.A. Demery, M.C. Liu, J.J. Tepas 3rd, A. Gabrielli, S. Robicsek, K.K. Wang, C.S. Robertson, and R.L. Hayes alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury J Neurotrauma 26 2009 471 479
13. A. Buki, R. Siman, J.Q. Trojanowski, and J.T. Povlishock The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury J Neuropathol Exp Neurol 58 1999 365 375
14. F. Cao, X.F. Yang, W.G. Liu, W.W. Hu, G. Li, X.J. Zheng, F. Shen, X.Q. Zhao, and S.T. Lv Elevation of neuron-specific enolase and S-100beta protein level in experimental acute spinal cord injury J Clin Neurosci 15 2008 541 544
15. P. Cengiz, F. Zemlan, R. Ellenbogen, D. Hawkins, and J.J. Zimmerman Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus Pediatr Crit Care Med 9 2008 524 529
16. A. Chen, and J.E. Springer Neuroproteomic methods in spinal cord injury Methods Mol Biol 566 2009 57 67
17. X.H. Chen, D.F. Meaney, B.N. Xu, M. Nonaka, T.K. McIntosh, J.A. Wolf, K.E. Saatman, and D.H. Smith Evolution of neurofilament subtype accumulation in axons following diffuse brain injury in the pig J Neuropathol Exp Neurol 58 1999 588 596
18. M.P. Coleman, and R.R. Ribchester Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system Curr Drug Targets CNS Neurol Disord 3 2004 227 238
19. J.R. de Kruijk, P. Leffers, P.P. Menheere, S. Meerhoff, and A. Twijnstra S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls Acta Neurol Scand 103 2001 175 179
20. A.S. Dumont, R.J. Dumont, and R.J. Oskouian Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention? Curr Opin Neurol 15 2002 713 720
21. L.F. Eng, J.J. Vanderhaeghen, A. Bignami, and B. Gerstl An acidic protein isolated from fibrous astrocytes Brain Res 28 1971 351 354
22. M.M. Folkerts, R.F. Berman, J.P. Muizelaar, and J.A. Rafols Disruption of MAP-2 immunostaining in rat hippocampus after traumatic brain injury J Neurotrauma 15 1998 349 363
23. C.C. Garner, R.P. Tucker, and A. Matus Selective localization of messenger RNA for cytoskeletal protein MAP2 in dendrites Nature 336 1988 674 677
24. C. Geyer, A. Ulrich, G. Grafe, B. Stach, and H. Till Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury J Neurosurg Pediatr 4 2009 339 344
25. B. Gong, and E. Leznik The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders Drug News Perspect 20 2007 365 370
26. A.R. Guerrero, K. Uchida, H. Nakajima, S. Watanabe, M. Nakamura, W.E. Johnson, and H. Baba Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice J Neuroinflammation 9 2012 40
27. M. Guez, C. Hildingsson, L. Rosengren, K. Karlsson, and G. Toolanen Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma J. Neurotrauma 20 2003 853 858
28. M.N. Hadley, B.C. Walters, P.A. Grabb, N.M. Oyesiku, G.J. Przybylski, D.K. Resnick, T.C. Ryken, and D.H. Mielke Guidelines for the management of acute cervical spine and spinal cord injuries Clin Neurosurg 49 2002 407 498
29. A. Hamberger, Y.L. Huang, H. Zhu, F. Bao, M. Ding, K. Blennow, A. Olsson, H.A. Hansson, D. Viano, and K.G. Haglid Redistribution of neurofilaments and accumulation of beta-amyloid protein after brain injury by rotational acceleration of the head J Neurotrauma 20 2003 169 178
30. V.H. Hans, T. Kossmann, P.M. Lenzlinger, R. Probstmeier, H.G. Imhof, O. Trentz, and M.C. Morganti-Kossmann Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid J Cereb Blood Flow Metab 19 1999 184 194
31. K. Hayakawa, R. Okazaki, K. Ishii, T. Ueno, N. Izawa, Y. Tanaka, S. Toyooka, N. Matsuoka, K. Morioka, Y. Ohori, K. Nakamura, M. Akai, Y. Tobimatsu, Y. Hamabe, and T. Ogata Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study Spinal Cord 50 2012 493 496
32. M. Herrmann, P. Vos, M.T. Wunderlich, C.H. de Bruijn, and K.J. Lamers Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein Stroke 31 2000 2670 2677
33. M. Honda, R. Tsuruta, T. Kaneko, S. Kasaoka, T. Yagi, M. Todani, M. Fujita, T. Izumi, and T. Maekawa Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase J Trauma 69 2010 104 109
34. B.R. Hu, C.L. Liu, Y. Ouyang, K. Blomgren, and B.K. Siesjo Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation J Cereb Blood Flow Metab 20 2000 1294 1300
35. J.W. Huh, M.A. Franklin, A.G. Widing, and R. Raghupathi Regionally distinct patterns of calpain activation and traumatic axonal injury following contusive brain injury in immature rats Dev Neurosci 28 2006 466 476
36. M. Iino, M. Nakatome, Y. Ogura, H. Fujimura, H. Kuroki, H. Inoue, Y. Ino, T. Fujii, T. Terao, and R. Matoba Real-time PCR quantitation of FE65 a beta-amyloid precursor protein-binding protein after traumatic brain injury in rats Int J Legal Med 117 2003 153 159
37. T. Ingebrigtsen, and B. Romner Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury Restor Neurol Neurosci 21 2003 171 176
38. P. Jackson, and R.J. Thompson The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis J Neurol Sci 49 1981 429 438
39. S.S. Jafari, W.L. Maxwell, M. Neilson, and D.I. Graham Axonal cytoskeletal changes after non-disruptive axonal injury J Neurocytol 26 1997 207 221
40. C.B. Jeter, G.W. Hergenroeder, M.J. Hylin, J.B. Redell, A.N. Moore, and P.K. Dash Biomarkers for the diagnosis and prognosis of mild traumatic brain injury/concussion J Neurotrauma 30 2013 657 670
41. G.C. Jickling, and F.R. Sharp Blood biomarkers of ischemic stroke Neurotherapeutics 8 2011 349 360
42. P. Johnsson, S. Blomquist, C. Luhrs, G. Malmkvist, C. Alling, J.O. Solem, and E. Stahl Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation Ann Thorac Surg 69 2000 750 754
43. S.K. Kang, H.H. So, Y.S. Moon, and C.H. Kim Proteomic analysis of injured spinal cord tissue proteins using 2-DE and MALDI-TOF MS Proteomics 6 2006 2797 2812
44. J.N. Keller, F.F. Huang, H. Zhu, J. Yu, Y.S. Ho, and T.S. Kindy Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury J Cereb Blood Flow Metab 20 2000 1467 1473
45. F.H. Kobeissy, A.K. Ottens, Z. Zhang, M.C. Liu, N.D. Denslow, J.R. Dave, F.C. Tortella, R.L. Hayes, and K.K. Wang Novel differential neuroproteomics analysis of traumatic brain injury in rats Mol Cell Proteomics 5 2006 1887 1898
46. F.H. Kobeissy, S. Sadasivan, M.W. Oli, G. Robinson, S.F. Larner, Z. Zhang, R.L. Hayes, and K.K. Wang Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation Proteomics Clin Appl 2 2008 1467 1483
47. P.M. Kochanek, R.P. Berger, H. Bayir, A.K. Wagner, L.W. Jenkins, and R.S. Clark Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making Curr Opin Crit Care 14 2008 135 141
48. K.E. Kouadjo, Y. Nishida, J.F. Cadrin-Girard, M. Yoshioka, and J. St-Amand Housekeeping and tissue-specific genes in mouse tissues BMC Genomics 8 2007 127
49. E. Kovesdi, J. Luckl, P. Bukovics, O. Farkas, J. Pal, E. Czeiter, D. Szellar, T. Doczi, S. Komoly, and A. Buki Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics Acta Neurochir (Wien) 152 2010 1 17
50. J.F. Kraus, C.E. Franti, R.S. Riggins, D. Richards, and N.O. Borhani Incidence of traumatic spinal cord lesions J Chronic Dis 28 1975 471 492
51. B.K. Kwon, S. Casha, R.J. Hurlbert, and V.W. Yong Inflammatory and structural biomarkers in acute traumatic spinal cord injury Clin Chem Lab Med 49 2011 425 433
52. B.K. Kwon, A.M. Stammers, L.M. Belanger, A. Bernardo, D. Chan, C.M. Bishop, G.P. Slobogean, H. Zhang, H. Umedaly, M. Giffin, J. Street, M.C. Boyd, S.J. Paquette, C.G. Fisher, and M.F. Dvorak Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury J Neurotrauma 27 2010 669 682
53. H. Laser, T.G. Mack, D. Wagner, and M.P. Coleman Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture J Neurosci Res 74 2003 906 916
54. S.J. Lee, C.W. Kim, K.J. Lee, J.W. Choe, S.E. Kim, J.H. Oh, and Y.S. Park Elevated serum S100B levels in acute spinal fracture without head injury Emerg Med J 27 2010 209 212
55. X.Y. Li, and D.F. Feng Diffuse axonal injury: novel insights into detection and treatment J Clin Neurosci 16 2009 614 619
56. S. Lincoln, J. Vaughan, N. Wood, M. Baker, J. Adamson, K. Gwinn-Hardy, T. Lynch, J. Hardy, and M. Farrer Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease Neuroreport 10 1999 427 429
57. M.C. Liu, L. Akinyi, D. Scharf, J. Mo, S.F. Larner, U. Muller, M.W. Oli, W. Zheng, F. Kobeissy, L. Papa, X.C. Lu, J.R. Dave, F.C. Tortella, R.L. Hayes, and K.K. Wang Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats Eur J Neurosci 31 2010 722 732
58. M.C. Liu, V. Akle, W. Zheng, J. Kitlen, B. O'Steen, S.F. Larner, J.R. Dave, F.C. Tortella, R.L. Hayes, and K.K. Wang Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury J Neurochem 98 2006 700 712
59. D.N. Loy, A.E. Sroufe, J.L. Pelt, D.A. Burke, Q.L. Cao, J.F. Talbott, and S.R. Whittemore Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta Neurosurgery 56 2005 391 397 discussion 391-397
60. K.M. Lumpkins, G.V. Bochicchio, K. Keledjian, J.M. Simard, M. McCunn, and T. Scalea Glial fibrillary acidic protein is highly correlated with brain injury J Trauma 65 2008 778 782 discussion 782-774
61. J. Ma, L.N. Novikov, K. Karlsson, J.O. Kellerth, and M. Wiberg Plexus avulsion and spinal cord injury increase the serum concentration of S-100 protein: an experimental study in rats Scand J Plast Reconstr Surg Hand Surg 35 2001 355 359
62. G. Marquardt, M. Setzer, and V. Seifert Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100 beta Neurosurgery 58 2006 E590 author reply E590
63. G. Marquardt, M. Setzer, A. Szelenyi, V. Seifert, and R. Gerlach Significance of serial S100b and NSE serum measurements in surgically treated patients with spondylotic cervical myelopathy Acta Neurochir (Wien) 151 2009 1439 1443
64. G. Marquardt, M. Setzer, A. Theisen, D.S. Tews, and V. Seifert Experimental subacute spinal cord compression: correlation of serial S100B and NSE serum measurements, histopathological changes, and outcome Neurol Res 33 2011 421 426
65. A. Matus Neurofilament protein phosphorylation - where, when and why Trends Neurosci 11 1988 291 292
66. U. Missler, M. Wiesmann, C. Friedrich, and M. Kaps S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke Stroke 28 1997 1956 1960
67. S. Mondello, S.A. Robicsek, A. Gabrielli, G.M. Brophy, L. Papa, J. Tepas, C. Robertson, A. Buki, D. Scharf, M. Jixiang, L. Akinyi, U. Muller, K.K. Wang, and R.L. Hayes alphaII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients J Neurotrauma 27 2010 1203 1213
68. S. Mondello, A. Jeromin, A. Buki, R. Bullock, E. Czeiter, N. Kovacs, P. Barzo, K. Schmid, F.C. Tortella, K.K. Wang, and R.L. Hayes Glial neuronal ratio (GNR): a novel index for differentiating injury type in patients with severe traumatic brain injury J Neurotrauma 29 2011 1096 1104
69. S. Mondello, U. Muller, A. Jeromin, J. Streeter, R.L. Hayes, and K.K. Wang Blood-based diagnostics of traumatic brain injuries Exp Rev Mol Diagn 11 2011 65 78
70. S. Mondello, A. Linnet, A. Buki, S. Robicsek, A. Gabrielli, J. Tepas, L. Papa, G.M. Brophy, F. Tortella, R.L. Hayes, and K.K. Wang Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury Neurosurgery 70 2012 666 675
71. R. Morochovic, O. Racz, M. Kitka, S. Pingorova, P. Cibur, D. Tomkova, and R. Lenartova Serum S100B protein in early management of patients after mild traumatic brain injury Eur J Neurol 16 2009 1112 1117
72. P.E. Mouser, E. Head, K.H. Ha, and T.T. Rohn Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain Am J Pathol 168 2006 936 946
73. K. Nylen, M. Ost, L.Z. Csajbok, I. Nilsson, K. Blennow, B. Nellgard, and L. Rosengren Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome J Neurol Sci 240 2006 85 91
74. J.B. Olmsted Microtubule-associated proteins Annu Rev Cell Biol 2 1986 421 457
75. M. Ost, K. Nylen, L. Csajbok, A.O. Ohrfelt, M. Tullberg, C. Wikkelso, P. Nellgard, L. Rosengren, K. Blennow, and B. Nellgard Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury Neurology 67 2006 1600 1604
76. A.K. Ottens, E.C. Golden, L. Bustamante, R.L. Hayes, N.D. Denslow, and K.K. Wang Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry J Neurochem 104 2008 1404 1414
77. C.A. Oyinbo Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade Acta Neurobiol Exp (Wars) 71 2011 281 299
78. L. Papa, L. Akinyi, M.C. Liu, J.A. Pineda, J.J. Tepas 3rd, M.W. Oli, W. Zheng, G. Robinson, S.A. Robicsek, A. Gabrielli, S.C. Heaton, H.J. Hannay, J.A. Demery, G.M. Brophy, J. Layon, C.S. Robertson, R.L. Hayes, and K.K. Wang Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury Crit Care Med 38 2010 138 144
79. L. Papa, L.M. Lewis, J.L. Falk, Z. Zhang, S. Silvestri, P. Giordano, G.M. Brophy, J.A. Demery, N.K. Dixit, I. Ferguson, M.C. Liu, J. Mo, L. Akinyi, K. Schmid, S. Mondello, C.S. Robertson, F.C. Tortella, R.L. Hayes, and K.K. Wang Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention Ann Emerg Med 59 2012 471 483
80. E. Park, E. Liu, M. Shek, A. Park, and A.J. Baker Heavy neurofilament accumulation and alpha-spectrin degradation accompany cerebellar white matter functional deficits following forebrain fluid percussion injury Exp Neurol 204 2007 49 57
81. L.E. Pelinka, N. Harada, L. Szalay, M. Jafarmadar, H. Redl, and S. Bahrami Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats Shock 21 2004 72 76
82. L.E. Pelinka, H. Hertz, W. Mauritz, N. Harada, M. Jafarmadar, M. Albrecht, H. Redl, and S. Bahrami Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings Shock 24 2005 119 123
83. L.E. Pelinka, A. Kroepfl, M. Leixnering, W. Buchinger, A. Raabe, and H. Redl GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome J Neurotrauma 21 2004 1553 1561
84. L.E. Pelinka, A. Kroepfl, R. Schmidhammer, M. Krenn, W. Buchinger, H. Redl, and A. Raabe Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma J Trauma 57 2004 1006 1012
85. A. Petzold Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss J Neurol Sci 233 2005 183 198
86. B.R. Pike, J. Flint, J.R. Dave, X.C. Lu, K.K. Wang, F.C. Tortella, and R.L. Hayes Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats J Cereb Blood Flow Metab 24 2004 98 106
87. B.R. Pike, J. Flint, S. Dutta, E. Johnson, K.K. Wang, and R.L. Hayes Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats J Neurochem 78 2001 1297 1306
88. M.H. Pouw, A.J. Hosman, J.J. van Middendorp, M.M. Verbeek, P.E. Vos, and H. van de Meent Biomarkers in spinal cord injury Spinal Cord 47 2009 519 525
89. A. Raabe, C. Grolms, M. Keller, J. Dohnert, O. Sorge, and V. Seifert Correlation of computed tomography findings and serum brain damage markers following severe head injury Acta Neurochir (Wien) 140 1998 787 791 discussion 791-782
90. A. Raabe, C. Grolms, O. Sorge, M. Zimmermann, and V. Seifert Serum S-100B protein in severe head injury Neurosurgery 45 1999 477 483
91. T.M. Reeves, J.E. Greer, A.S. Vanderveer, and L.L. Phillips Proteolysis of submembrane cytoskeletal proteins ankyrin-G and alphaII-spectrin following diffuse brain injury: a role in white matter vulnerability at Nodes of Ranvier Brain Pathol 20 2010 1055 1068
92. N.C. Ringger, B.E. O'Steen, J.G. Brabham, X. Silver, J. Pineda, K.K. Wang, R.L. Hayes, and L. Papa A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels J Neurotrauma 21 2004 1443 1456
93. B. Romner, T. Ingebrigtsen, P. Kongstad, and S.E. Borgesen Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings J Neurotrauma 17 2000 641 647
94. S.A. Ross, R.T. Cunningham, C.F. Johnston, and B.J. Rowlands Neuron-specific enolase as an aid to outcome prediction in head injury Br J Neurosurg 10 1996 471 476
95. P.A. Schumacher, J.H. Eubanks, and M.G. Fehlings Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury Neuroscience 91 1999 733 744
96. G. Serbest, M.F. Burkhardt, R. Siman, R. Raghupathi, and K.E. Saatman Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice Neurochem Res 32 2007 2006 2014
97. G. Shaw, C. Yang, R. Ellis, K. Anderson, J. Parker Mickle, S. Scheff, B. Pike, D.K. Anderson, and D.R. Howland Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury Biochem Biophys Res Commun 336 2005 1268 1277
98. G.J. Shaw, E.C. Jauch, and F.P. Zemlan Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury Ann Emerg Med 39 2002 254 257
99. N. Shiiya, T. Kunihara, T. Miyatake, K. Matsuzaki, and K. Yasuda Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery Ann Thorac Surg 77 2004 2034 2038
100. J.E. Springer, R.D. Azbill, S.E. Kennedy, J. George, and J.W. Geddes Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment J Neurochem 69 1997 1592 1600
101. C.E. Teunissen, C. Dijkstra, and C. Polman Biological markers in CSF and blood for axonal degeneration in multiple sclerosis Lancet Neurol 4 2005 32 41
102. S.N. Thompson, T.R. Gibson, B.M. Thompson, Y. Deng, and E.D. Hall Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice Exp Neurol 201 2006 253 265
103. P. Tongaonkar, L. Chen, D. Lambertson, B. Ko, and K. Madura Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome Mol Cell Biol 20 2000 4691 4698
104. T. Ueno, Y. Ohori, J. Ito, S. Hoshikawa, S. Yamamoto, K. Nakamura, S. Tanaka, M. Akai, Y. Tobimatsu, and T. Ogata Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury Spinal Cord 49 2011 333 336
105. M.E. van den Berg, J.M. Castellote, I. Mahillo-Fernandez, and J. de Pedro-Cuesta Incidence of spinal cord injury worldwide: a systematic review Neuroepidemiology 34 2010 184 192 discussion 192
106. P.E. Vos, B. Jacobs, T.M. Andriessen, K.J. Lamers, G.F. Borm, T. Beems, M. Edwards, C.F. Rosmalen, and J.L. Vissers GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study Neurology 75 2010 1786 1793
107. P.E. Vos, K.J. Lamers, J.C. Hendriks, M. van Haaren, T. Beems, C. Zimmerman, W. van Geel, H. de Reus, J. Biert, and M.M. Verbeek Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury Neurology 62 2004 1303 1310
108. K.K. Wang, A.K. Ottens, M.C. Liu, S.B. Lewis, C. Meegan, M.W. Oli, F.C. Tortella, and R.L. Hayes Proteomic identification of biomarkers of traumatic brain injury Expert Rev Proteomics 2 2005 603 614
109. K.K. Wang, R. Posmantur, R. Nath, K. McGinnis, M. Whitton, R.V. Talanian, S.B. Glantz, and J.S. Morrow Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells J Biol Chem 273 1998 22490 22497
110. I.B. Wanner, A. Deik, M. Torres, A. Rosendahl, J.T. Neary, V.P. Lemmon, and J.L. Bixby A new in vitro model of the glial scar inhibits axon growth Glia 56 2008 1691 1709
111. P.M. Whitaker-Azmitia, M. Wingate, A. Borella, R. Gerlai, J. Roder, and E.C. Azmitia Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome Brain Res 776 1997 51 60
112. A. Winnerkvist, R.E. Anderson, L.O. Hansson, L. Rosengren, A.E. Estrera, T.T. Huynh, E.E. Porat, and H.J. Safi Multilevel somatosensory evoked potentials and cerebrospinal proteins: indicators of spinal cord injury in thoracoabdominal aortic aneurysm surgery Eur J Cardiothorac Surg 31 2007 637 642
113. H.M. Wu, S.C. Huang, N. Hattori, T.C. Glenn, P.M. Vespa, C.L. Yu, D.A. Hovda, M.E. Phelps, and M. Bergsneider Selective metabolic reduction in gray matter acutely following human traumatic brain injury J Neurotrauma 21 2004 149 161
114. M. Wyndaele, and J.J. Wyndaele Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord 44 2006 523 529
115. Y. Yamazaki, K. Yada, S. Morii, T. Kitahara, and T. Ohwada Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury Surg Neurol 43 1995 267 270 discussion 270-261
116. W.R. Yu, and M.G. Fehlings Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application Acta Neuropathol 122 2011 747 761
117. F.P. Zemlan, E.C. Jauch, J.J. Mulchahey, S.P. Gabbita, W.S. Rosenberg, S.G. Speciale, and M. Zuccarello C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome Brain Res 947 2002 131 139
118. F.P. Zemlan, W.S. Rosenberg, P.A. Luebbe, T.A. Campbell, G.E. Dean, N.E. Weiner, J.A. Cohen, R.A. Rudick, and D. Woo Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins J Neurochem 72 1999 741 750
119. B. Zhang, Y. Huang, Z. Su, S. Wang, J. Wang, A. Wang, and X. Lai Neurological, functional, and biomechanical characteristics after high-velocity behind armor blunt trauma of the spine J Trauma 71 2011 1680 1688
120. S.X. Zhang, M. Underwood, A. Landfield, F.F. Huang, S. Gison, and J.W. Geddes Cytoskeletal disruption following contusion injury to the rat spinal cord J Neuropathol Exp Neurol 59 2000 287 296
121. D.B. Zimmer, E.H. Cornwall, A. Landar, and W. Song The S100 protein family: history, function, and expression Brain Res Bull 37 1995 417 429